
In the country, the tendency of consuming antibiotics and antimicrobial drugs from medical stores without doctor’s advice as soon as one has mild fever, cold or sore throat has now become a serious national health crisis. To stop this dangerous trend and the rapidly spreading threat of Antimicrobial Resistance (AMR) i.e. drug-resistant bacteria (Superbugs), the Union Health Ministry and the drug regulatory body CDSCO (Central Drugs Standard Control Organization) have started preparations to take a historic and very strict step. Under the new proposal, a plan has been made to permanently keep all antimicrobial drugs in the country in the ‘New Drug’ category. After the implementation of this rule, there will be direct and lifelong supervision of the Central Government on the manufacturing, licensing, marketing and retail sale of these medicines.
According to the current New Drugs and Clinical Trials Rules, 2019, when a new drug is approved in India for the first time, it is kept in the category of ‘New Drug’ for the first 4 years. During this 4-year period, only the Drugs Controller General of India (DCGI), the apex regulator of the central government, has the authority to grant permission for the manufacture and sale of that drug, and pharma companies have to submit regular data on safety and effectiveness. But as soon as the time limit of 4 years was completed, that drug would come out of the list of ‘New Drug’ and become a normal drug, after which the State Licensing Authorities of the states would also issue licenses to a large number of local companies to produce that drug. Now in the new proposal, it has been recommended to permanently declare antimicrobial drugs as ‘New Drugs’ by ending this 4-year time limit, which will completely stop their uncontrolled production and making of Fixed Dose Combination (FDC) at any state level.
According to medical experts and the World Health Organization (WHO), India is among the countries in the world where consumption of antibiotics is highest. When people take high-dose antibiotics for viral fever, common cough or even minor infections without medical advice or leave the entire course of medicine midway, the bacteria and microorganisms present within the body develop resistance to those medicines. This is called antimicrobial resistance (AMR). As a result, in the future, when the same person gets pneumonia, typhoid, urinary tract infection (UTI) or any serious infection after surgery, even simple to powerful antibiotics stop working on the body. Scientists have warned that if it is not controlled in time, even minor injuries or infections can prove fatal in the coming decades.
After the implementation of this proposal, a major change will be seen in the functioning of the pharmaceutical market. First, pharmaceutical companies will have to obtain approval directly from DCGI every time they produce any antimicrobial drug or its new combination, only after rigorous scientific trials, which will stop the flood of unnecessary and poor quality antibiotic brands in the market. Second, compliance with the rules of Schedule H and Schedule H1 (Schedule H & H1) will be enforced more strictly on retail chemists and medical store operators. Now no chemist will be able to sell antibiotics without a valid prescription from a registered doctor, and it will be mandatory for him to maintain complete records of each sale—name of the patient, name of the doctor and quantity of the medicine—in a register or digital portal.
Health experts from across the country including Lucknow, New Delhi, Mumbai, Jaipur and Patna have strongly welcomed this proposal of the Central Government. Doctors say this step will prove to be a milestone in preserving the effectiveness of life-saving medicines for future generations. Common citizens will also have to improve their habits and understand that every fever or cold does not require antibiotics, because antibiotics have no effect on viral infections. Always take the medicine as per the advice of a qualified doctor, complete the prescribed dose and the full course of days and never use the remaining antibiotic medicine prescribed for someone else.
look news india